BASEL, Switzerland - Bruker (NASDAQ:BRKR) Corporation (NASDAQ:BRKR), a global scientific instrumentation company, has finalized the purchase of Chemspeed Technologies AG, a Swiss firm specializing in automated laboratory solutions for research and development (R&D) and quality control (QC). This acquisition, part of Bruker’s Project Accelerate 2.0, aims to enhance its offerings in scientific software and laboratory automation.
The transaction, which was initially announced in January 2024, is expected to contribute approximately $10 million in revenue per quarter for Chemspeed, as it shifts to US GAAP reporting and adapts to Bruker's revenue recognition policies. By 2025, Chemspeed is anticipated to add 2-3 cents to Bruker’s non-GAAP earnings per share (EPS). The company also forecasts organic revenue growth in the high single digits to low double digits and significant margin expansion moving forward.
Bernd Gleixner, President of Bruker BioSpin's Automation Division and now Managing Director of Chemspeed, expressed enthusiasm for the acquisition, emphasizing the continued operation of Chemspeed as a vendor-agnostic entity within Bruker. The focus remains on industry-leading automated laboratory solutions and customer service.
Chemspeed's modular and compact FLEX automation workstations aim to improve productivity and quality in chemical and materials science R&D labs while also enhancing the return on R&D investment.
Bruker Corporation is known for its high-performance scientific instruments and analytical and diagnostic solutions. The company's products support scientific research at molecular, cellular, and microscopic levels across various fields, including life science research, applied and pharmaceutical applications, microscopy, nanoanalysis, and industrial applications.
The information in this article is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.